The challenge of molecular medicine: complexity versus Occam's razor.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Remodeling of calcium handling in human heart failure.Advances in experimental medicine and biology · 2012
   Review
2. A novel information retrieval model for high-throughput molecular medicine modalities.Cancer informatics · 2009
   Article
3. Orphaned ryanodine receptors in the failing heart.Proceedings of the National Academy of Sciences of the United States of America · 2006
   Article
4. Return of calcium: manipulating intracellular calcium to prevent cardiac pathologies.Proceedings of the National Academy of Sciences of the United States of America · 2004
   Article

Corrections and comments

• Comment on
  Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.2003
• Comment on
  Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.2003

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as